HESG...1.14 copy of a recent RB post that makes the best possible case for HESG success:
Highlights from the Super Stock Investor report on HESG:
Two years ago, two business visionaries, Bill Glaser and Fred E. Tannous, moved into this field by merging two smaller companies to form one publicly-traded entity, Health Sciences Group, Inc. (HESG) These guys are moving fast, and snapping up new products and technologies at the earliest stage, for the best possible price. HESG has been picking up new technologies from a variety of sources. They have been working with the University of Massachusetts, Texas A&M, Cornell University, Tokyo University and five Korean universities. HESG is acquiring partners and strategic alliances across Asia and Europe - companies with proven R&D to develop new products, and other relationships with established sales networks.
Their business plan is based on three objectives:
• Search for new, overlooked technologies in the nutraceutical field and acquire the exclusive worldwide rights.
• Apply those technologies to large markets currently dominated by old technologies. Go after the sitting ducks!
• Focus entirely on R&D and marketing, while contracting out the manufacturing.
(A notorious asset-waster.)
The $19 Billion Cholesterol Market
One of the Companies HESG is partnered with is a Korean Company whose advanced biochemical research scientists have developed a marketable product named Sequestrol now covered by eight patents and patents-pending worldwide. HESG owns the worldwide rights (outside of Korea) to this natural non-prescription cholesterol-reducer that 's already an overseas best-seller (millions of people abroad love this powerful cholesterol fighter) & approved by the FDA for this country. Sequestrol is an odorless/tasteless powder that comes from seaweed and kelp, using a patented extraction and purification process. (And it's full scientific name is Low Molecular Weight Polymannuronate.) Sequestrol is also used as a cholesterol-lowering additive in baked goods and other food products. The more you eat, the more you cut your cholesterol.
Sequestrol has been impressive in clinical trials. In one typical clinical study conducted on 57 patients, 3g/day of Sequestrol was administered orally without restricting food intake or altering the normal diet. After 30 days, the cholesterol level in all patients had decreased by at least 22.7%. Many reached those levels within 15 days.
In another clinical trial with HESG's drug buster, the LDL-cholesterol level (bad cholesterol) was lowered by 59% in the serum and by 74% in the liver - while the HDL-cholesterol level (good cholesterol) increased by 4.6 times in the serum and 1.2 times in the liver. In the same study, the triglyceride level decreased by 42% in the serum and by 48% in the liver. So why is Sequestrol going to be such a big deal in the U.S.? HESG is riding the demographic trends with Sequestrol: Americans are getting fatter and older and 37 million people have high levels of cholesterol. Twelve million Americans currently take statin drugs - plus millions of foreigners - each spending $1,100 a year for their cholestrol control. Statin drugs are the world's largest, most lucrative pharmaceutical goldmine. Annual sales are nearing $20 billion, and the profits are obscene. . But now the statins are being questioned - in The New York Times, Time, Newsweek, Consumer's Report, Forbes, all the TV networks, etc. - and attacked in Congress. They are being linked to lower attention span and motor skills, muscle breakdown, kidney damage, bad interactions with ibuprofens, etc. A high FDA official even admitted that Crestor, another statin, was unsafe. Hearings are getting underway in Congress, and class-action lawyers are moving into action. Just like Vioxx, all over again. (And is Celebrex next?)
Can any other natural cholesterol-reducing product match the extraordinary numbers for HESG's Sequestrol? After all, how many people with mid-levels of cholesterol would throw away a hundred dollars a month on Lipitor or some other statin - when it could harm them? HESG's Sequestrol® is safe…natural…more effective...80% cheaper…clinically proven to cut cholesterol up to 30%. Why pay $100 a month for a statin drug if Sequestrol offers the same benefits for around $20? Why take something risky when you can take a NO-risk equivalent?
Where will users turn if they want something different? Their choice: Stick to a rigorous low-fat diet and take plenty of exercise (which most people won't do) OR take affordable Sequestrol. If just 5% switch to Sequestrol, that would generate annual sales for HESG of $150 million.
• 20 million Americans should be taking something to lower their cholesterol but they're NOT. If only 2% follow the overseas practice and take this preventative nutraceutical, Sequestrol would produce another $150 million for HESG.
• Worldwide sales? HESG is targeting Asia and Europe for licensing agreements and joint ventures. Net annual revenue after four years: Early studies indicate an annual revenue after four years of $70 million.
• Bulk sales. Foreign food manufacturers are now adding this product to their ingredients, creating a significant selling point. ("Fight cholesterol while you eat!") Huge potential in the U.S. Market research estimates annual revenue after four years exceeding $70 million.
Total annual sales projected for Sequestrol within four years: $400 million - but that could quickly jump to a BILLION.
They've got the option of taking a natural cholesterol-reducer in a capsule or as an added ingredient cooked into their food. This way, they can eat not-so-healthy foods if they choose, cheat on their exercise and still keep their cholesterol down. HESG's spectacular drug buster is expected to start rolling out to such stores as GNC, Eckerd Drugs, Rite Aid, CVS, super-market chains and elsewhere. For the first time, millions of people will be given a fresh option
SHUGR:
Obesity is a major a health crisis…sugar accounts for 20% of our calories - so why aren't more zero calorie sweeteners used in pies, cakes, candy, snacks, etc.? Because Sweet 'n' Low, Equal and Splenda can't be used for cooking. Chefs won't touch the stuff because those fake sweeteners just don't work. HESG's Shugr beats Splenda, Seet 'n' Low, Equal. World's first 0 calorie natural sweetener and the perfect substitute for sugar. Ideal for cooking. HESG's Shugr: World's first zero calorie natural sweetener. And why would anyone use some artificial "sweetener" when they can have the real thing with no calories - that's tastes just like sugar, cooks like sugar, except it's not sugar? I have just tried a new zero-calorie sweetener from HESG that's indistinguishable from sugar. Shugr (its name) has full patent-pending protection and it changes everything.
Tastes and cooks just like sugar. No after-taste. (Unlike Equal, Splenda and Sweet 'n' Low.) FIRST TIME EVER!
• 100% tooth-friendly - can't cause cavities. (Unlike Splenda.)
• Safe, healthy and fully prebiotic. (Can't say that for the other sweeteners.)
• Safe for diabetics and FDA-approved.
• First zero calorie sweetener that CAN be used for cooking. Chefs are ecstatic!
The implications are mind-boggling: You can feast on candy and dessert WITHOUT watching your sugar calories. And all those breakfast cereals loaded with sugar that kids love? Let 'em eat it! The commercial potential is almost unlimited…
• Bulk sales to the food industry will boom, as only Shugr cooks and tastes just like sugar. NO COMPETITION! $2 billion market.
• Retail and fast food sales are almost unlimited. $1.5 billion market.
• New generation of 'Weight-Watcher'-type foods. $200 million market.
Patent-protected Shugr is 100% owned by Health Sciences Group Estimated annual revenue in four years: $70 million. (This projection is climbing by the month.).
COCARE
HESG invents a new market: OTC drugs + natural remedies = CoCare® -and HESG has full worldwide proprietary ownership of this potential billion dollar market. Health Sciences Groups, Inc. will make medical history in the fall of '05 with the introduction of its trail-blazing line of CoCare products for relief of colds and flu…cough suppression…migraine headaches…arthritis…acid reflux…urinary tract infection…and cardiac protection.
Here's the really big news. Until now, non-prescription medicines have either been over-the-counter (OTC) medications OR homeopathic or natural (herbal) remedies. One or the other…take your pick. But now for the first time, HESG will combine traditional OTCs with the natural remedies in a single product to treat these common problems. These hybrid products will offer many benefits.
• 'Bundling' means greater convenience. For example, consumers seeking arthritic relief had to purchase acetaminophen and glucosamine separately. Now they'll come together in one capsule - saving consumers the need to purchase a myriad of different products.
• 'Bundling is safer.' When taken together, the right balance between OTC and homeopathic medications is critically important - and the wrong balance can be dangerous. For the first time, CoCare will blend the right mix.
• 'Bundling' cuts down on dangerous bathroom cabinet clutter. Too many bottles for too many brands of pills…and the result? Tens of thousands of people are sickened every year - and occasionally die - by the adverse interaction between medicines. CoCare will go a long way towards solving this problem.
• Best of both worlds. OTC medications offer certain advantages, as do natural remedies, but many people take one or the other. But TOGETHER, both can offer a total treatment that's greater than individual parts. Soon, for the first time, HESG will bring them together.
• Greater affordable health for millions of people by combining the advances of science with natural remedies.
CoCare will allow Health Sciences Group, Inc. to expand the reach of nutraceuticals into the mass market by combining them with the ubiquitous OTC drugs. This could be a brand-new BILLION DOLLAR MARKET. It could also be spun-off as a separate company - or become a lucrative joint venture with a major pharmaceutical company - further enriching HESG shareholders.
The CoCare breakthrough, all by itself, could turn HESG into a drug giant.
World's Most Powerful Antioxidant?
On Nov. 23 '04 HESG acquired exclusive worldwide rights to a significant nutraceutical breakthrough from Cornell University. Medical researchers at Cornell University, in New York, have discovered what could be a potent new weapon against &Alzheimer's and cancer (deadly free radicals). This clinically proven technology uses a proprietary process to extract and preserve the phytochemical content found in apple peels. Significance? The high-oxidant powder that comes from apple peels - and only the peels and only from apples! - can stop the damage caused by free radicals, a prime cause of cancer and Alzheimer's. This latter condition affects 4.5 million people in the U.S. In studies conducted at Cornell, researchers show that brain cells treated with the apple antioxidants had significantly less damage than those treated with vitamin C or not exposed to antioxidants, according to C.Y. Lee, Professor and Chairman of the Department of Food Science & Technology. HESG will be using the powder as a nutraceutical ingredient and supplement in cereals, sauces, granola and energy bars, etc. This apple peel powder will be offered for sale as a branded product. It will eventually be available worldwide. As an added commercial incentive, apple peels are currently regarded as a waste product. Thus the cost of the raw material to make this powder is near-zero.
Each of these finished products only use FDA-approved ingredients, and are powered by HESG proprietary nutraceuticals. Each of them offers unique consumer benefits, and each has the potential to be a $100 million-a-year revenue-producer entirely on its own.
Finally, there's the "spin-off" potential. If highly successful products become separate companies, then HESG shareholders could reap an extra windfall.. HESG's new ultra-potent antioxidant technology from Cornell University could be a major weapon against deadly free radicals and could potentially treat cancer and Alzheimer's.
Skin Care:
Skin care and anti-aging. Possibly the world's most effective products for smoothing out wrinkles and conditioning hair - from HESG's Swiss Research brand. Health Sciences Swiss Research product line will be introducing what is possibly the world's most effective solution for smoothing out wrinkles and conditioning hair. This is a proprietary nanoencapsulation technology, NanoEGF®, that permits an ultra-high permeability coefficient. In plain English, that means a very high penetration that every dermatologist knows is all-important.
Here's something else with which dermatologists are very familiar: Most personal-care products that offer anti-wrinkle EGF are near-useless. Why? EGF costs a fortune ($200,000 a gram) and each product usually contains about one-MILLIONTH of a gram - which makes EGF just a marketing gimmick with no value. HESG will be launching a major breakthrough! Its Swiss Research family will consists of a dozen personal-care products to protect and nourish skin and hair, while reducing the effects of aging. Every woman knows that most anti-aging skincare products have little value - confirmed in consumer test labs. In contrast, HESG's new Swiss Research brand wrinkle-smoothing creams DO work, thanks to its proprietary nanoencapsulation technology.
Nutraceutical Technologies:
HESG has acquired nutraceutical technologies to help with improved joint mobility, immune deficiency and weight reduction. Any of these discoveries could be a major winner - and a BIG revenue generator.
• Calorie Minus®. Chewable tablets. Blocks 28% of the fat from a meal. ($900 million market)
• Swiss Diet Weight Loss Formula®. Cuts sugar cravings. Blocks carbohydrates. Reduces body fat. ($3 billion market.)
• Cell Source® Provides joint relief and flexibility for people with rheumatoid and osteoarthritis. ($4 billion market.)
• T-Cell 90®. Advanced oxyengenic formula to fight viral infections and compromised immune functions. ($2.7 billion market.)
New distribution channels are being readied to move HESG products: Stores like GNC, Eckerd Drugs, Rite Aid, CVS, super market chains. The company's management is already in the early planning stage of spinning off one or more product lines as separate companies, giving HESG shareholders a healthy chunk of the equity. |
